11:02 AM EDT, 05/01/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking lower late Thursday morning, declining 0.31% to 1,395.50 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by accommodations booking site trivago (TRVG) and biotech firm Evaxion Biotech ( EVAX ) , which advanced 33% and 2.6%, respectively. They were followed by furniture manufacturer Natuzzi (NTZ) and biopharmaceutical company Genfit ( GNFT ) , which increased 2.4% and 1.4%, respectively.

The decliners from continental Europe were led by biotech firm BioNTech (BNTX) and biopharmaceutical company Cellectis ( CLLS ) , which fell 3.1% and 2.4%, respectively. They were followed by pharmaceutical company Ascendis Pharma ( ASND ) and electronics conglomerate Philips (PHG), which lost 1.5% and 1.1%, respectively.

From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics ( SLN ) and biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) , which rose 5.5% and 4.8%, respectively. They were followed by biopharmaceutical company Bicycle Therapeutics ( BCYC ) and Endava ( DAVA ) , which were up 4% and 3.2%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company NuCana ( NCNA ) and education publisher Pearson (PSO), which dropped 5.6% and 2.9%, respectively. They were followed by financial services company Lloyds Banking Group ( LYG ) and pharmaceutical company AstraZeneca ( AZN ) , which were down 2.8% and 2.2%, respectively.